Registro:

Referencias:

• Etienne-Manneville, S., Hall, A., Rho GTPases in cell biology (2002) Nature, 420 (6916), pp. 629-635
• Bishop, A.L., Hall, A., Rho GTPases and their effector proteins (2000) Biochem. J, 348 (Pt 2), pp. 241-255
• Bosco, E.E., Mulloy, J.C., Zheng, Y., Rac1 GTPase: A Rac of all trades (2009) Cell Mol. Life Sci, 66 (3), pp. 370-374
• Ellenbroek, S.I., Collard, J.G., Rho GTPases: Functions and association with cancer (2007) Clin. Exp. Metastasis, 24 (8), pp. 657-672
• Fritz, G., Just, I., Kaina, B., Rho GTPases are over-expressed in human tumors (1999) Int. J. Cancer, 81 (5), pp. 682-687
• Fritz, G., Brachetti, C., Bahlmann, F., Schmidt, M., Kaina, B., Rho GTPases in human breast tumours: Expression and mutation analyses and correlation with clinical parameters (2002) Br. J. Cancer, 87 (6), pp. 635-644
• Kamai, T., Yamanishi, T., Shirataki, H., Takagi, K., Asami, H., Ito, Y., Yoshida, K., Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer (2004) Clin. Cancer Res, 10, pp. 4799-4805
• Buongiorno, P., Bapat, B., Rho GTPases and cancer (2005) Prog. Mol. Subcell. Biol, 40, pp. 29-53
• Schnelzer, A., Prechtel, D., Knaus, U., Dehne, K., Gerhard, M., Graeff, H., Harbeck, N., Lengyel, E., Rac1 in human breast cancer: Overexpression, mutation analysis, and characterization of a new isoform, Rac1b (2000) Oncogene, 19 (26), pp. 3013-3020
• Khosravi-Far, R., Solski, P.A., Clark, G.J., Kinch, M.S., Der, C.J., Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation (1995) Mol. Cell. Biol, 15, pp. 6443-6453
• Fritz, G., Kaina, B., Rho GTPases: Promising cellular targets for novel anticancer drugs (2006) Curr. Cancer Drug Targets, 6 (1), p. 1
• Vigil, D., Cherfils, J., Rossman, K.L., Der, C.J., Ras superfamily GEFs and GAPs: Validated and tractable targets for cancer therapy (2010) Nat. Rev. Cancer, 10 (12), pp. 842-857
• Krauthammer, M., Kong, Y., Ha, B.H., Evans, P., Bacchiocchi, A., McCusker, J.P., Cheng, E., Halaban, R., Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma (2012) Nat. Genet, 44 (9), pp. 1006-1014
• Hodis, E., Watson, I.R., Kryukov, G.V., Arold, S.T., Imielinski, M., Theurillat, J.P., Nickerson, E., Chin, L., A landscape of driver mutations in melanoma (2012) Cell, 150 (2), pp. 251-263
• Rossman, K.L., Der, C.J., Sondek, J., GEF means go: Turning on RHO GTPases with guanine nucleotide-exchange factors (2005) Nat. Rev. Mol. Cell Biol, 6 (2), pp. 167-180
• Fields, A.P., Justilien, V., The guanine nucleotide exchange factor (GEF) Ect2 is an oncogene in human cancer (2010) Adv. Enzyme Regul, 50 (1), pp. 190-200
• van Leeuwen, F.N., Van der Kammen, R.A., Habets, G.G., Collard, J.G., Oncogenic activity of Tiam1 and Rac1 in NIH3T3 cells (1995) Oncogene, 11 (11), pp. 2215-2221
• Gao, Y., Xing, J., Streuli, M., Leto, T.L., Zheng, Y., Trp(56) of rac1 specifies interaction with a subset of guanine nucleotide exchange factors (2001) J. Biol. Chem, 276 (50), pp. 47530-47541
• Karnoub, A.E., Worthylake, D.K., Rossman, K.L., Pruitt, W.M., Campbell, S.L., Sondek, J., Der, C.J., Molecular basis for Rac1 recognition by guanine nucleotide exchange factors (2001) Nat. Struct. Biol, 8 (12), pp. 1037-1041
• Wu, X., Ramachandran, S., Lin, M.C., Cerione, R.A., Erickson, J.W., A minimal Rac activation domain in the unconventional guanine nucleotide exchange factor Dock180 (2011) Biochemistry, 50 (6), pp. 1070-1080
• Shoichet, B.K., Virtual screening of chemical libraries (2004) Nature, 432 (7019), pp. 862-865
• Cosconati, S., Forli, S., Perryman, A.L., Harris, R., Goodsell, D.S., Olson, A.J., Virtual screening with autodock: Theory and practice (2010) Expert Opin. Drug Discov, 5 (6), pp. 597-607
• Irwin, J.J., Shoichet, B.K., ZINC--a free database of commercially available compounds for virtual screening (2005) J. Chem. Inf. Model, 45 (1), pp. 177-182
• Irwin, J.J., Sterling, T., Mysinger, M.M., Bolstad, E.S., Coleman, R.G., ZINC: A free tool to discover chemistry for biology (2012) J. Chem. Inf. Model, 52 (7), pp. 1757-1768
• Zsoldos, Z., Reid, D., Simon, A., Sadjad, S.B., Johnson, A.P., eHiTS: A new fast, exhaustive flexible ligand docking system (2007) J. Mol. Graph Model, 26 (1), pp. 198-212
• Morris, G.M., Huey, R., Olson, A.J., Using AutoDock for ligandreceptor docking (2008) Curr. Protoc. Bioinformatics, 8, p. 14. , Chapter 8:Unit
• Alonso, D.F., Farías, E.F., Urtreger, A., Ladeda, V., Vidal, M.C., de Kier, B., Joffé, E., Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma (1996) J. Surg. Oncol, 62 (4), pp. 288-297
• Best, A., Ahmed, S., Kozma, R., Lim, L., The Ras-related GTPase Rac1 binds tubulin (1996) J. Biol. Chem, 271 (7), pp. 3756-3762
• Habets, G.G., Scholtes, E.H., Zuydgeest, D., van der Kammen, R.A., Stam, J.C., Berns, A., Collard, J.G., Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins (1994) Cell, 77 (4), pp. 537-549
• Stam, J.C., Sander, E.E., Michiels, F., van Leeuwen, F.N., Kain, H.E., Van der Kammen, R.A., Collard, J.G., Targeting of Tiam1 to the plasma membrane requires the cooperative function of the Nterminal pleckstrin homology domain and an adjacent protein interaction domain (1997) J. Biol. Chem, 272 (45), pp. 28447-28454
• Sosa, M.S., Lopez-Haber, C., Yang, C., Wang, H., Lemmon, M.A., Busillo, J.M., Luo, J., Kazanietz, M.G., Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer (2011) Mol. Cell, 40, p. 877
• Segatori, V.I., Otero, L.L., Fernandez, L.E., Gomez, D.E., Alonso, D.F., Gabri, M.R., (2012) Antitumor Protection By NGcGM3/VSSP Vaccine Against Transfected B16 Mouse Melanoma Cells Overexpressing N-glycolylated Gangliosides, 26 (4), pp. 609-617. , In vivo
• Guidance Document on Using In Vitro Data to Estimate In Vivo Starting Doses for Acute Toxicity (2001) NIH Publication No, pp. 01-4500. , National Institute of Health (NIH)
• Fanger, G.R., Johnson, N.L., Johnson, G.L., MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42 (1997) EMBO J, 16 (16), pp. 4961-4972
• Itoh, R.E., Kiyokawa, E., Aoki, K., Nishioka, T., Akiyama, T., Matsuda, M., Phosphorylation and activation of the Rac1 and Cdc42 GEF Asef in A431 cells stimulated by EGF (2008) J. Cell Sci, 121 (Pt 16), pp. 2635-2642
• Menna, P.L., Skilton, G., Leskow, F.C., Alonso, D.F., Gomez, D.E., Kazanietz, M.G., Inhibition of aggressiveness of metastatic mouse mammary carcinoma cells by the beta2-chimaerin GAP domain (2003) Cancer Res, 63 (9), pp. 2284-2291
• Snyder, J.T., Worthylake, D.K., Rossman, K.L., Betts, L., Pruitt, W.M., Siderovski, D.P., Der, C.J., Sondek, J., Structural basis for the selective activation of Rho GTPases by Dbl exchange factors (2002) Nat. Struct. Biol, 9 (6), pp. 468-475
• Yang, C., Liu, Y., Leskow, F.C., Weaver, V.M., Kazanietz, M.G., Rac-GAP-dependent inhibition of breast cancer cell proliferation by {beta}2-chimerin (2005) J. Biol. Chem, 280 (26), pp. 24363-24370
• Montalvo-Ortiz, B.L., Castillo-Pichardo, L., Hernández, E., Humphries-Bickley, T., De la Mota-Peynado, A., Cubano, L.A., Vlaar, C.P., Dharmawardhane, S., Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase (2012) J. Biol. Chem, 287 (16), pp. 13228-13238
• Yoshida, T., Zhang, Y., Rivera, R.L.A., Chen, J., Khan, T., Moon, S.Y., Zhang, B., Blockade of Rac1 activity induces G1 cell cycle arrest or apoptosis in breast cancer cells through downregulation of cyclin D1, survivin, and X-linked inhibitor of apoptosis protein (2010) Mol. Cancer Ther, 9 (6), pp. 1657-1668
• Hall, A., Rho GTPases and the actin cytoskeleton (1998) Science, 279 (5350), pp. 509-514
• Ridley, Rho, A.J., GTPases and cell migration (2001) J. Cell Sci, 114 (Pt 15), pp. 2713-2722
• Li, S., Wang, Q., Wang, Y., Chen, X., Wang, Z., PLC-gamma1 and Rac1 coregulate EGF-induced cytoskeleton remodeling and cell migration (2009) Mol. Endocrinol, 23 (6), pp. 901-913
• Tetko, I.V., Gasteiger, J., Todeschini, R., Mauri, A., Livingstone, D., Ertl, P., Palyulin, V.A., Prokopenko, V.V., Virtual computational chemistry laboratory -design and description (2005) J. Comput. Aid. Mol. Des, 19 (6), pp. 453-463
• Montero, J.C., Seoane, S., Ocana, A., Pandiella, A., P-Rex1 participates in Neuregulin-ErbB signaltransduction and its expression correlates with patient outcome in breast cancer (2011) Oncogene, 30, pp. 1059-1071
• Han, S.S.R., Cho, C.K., Lee, Y.W., Yoo, H.S., Antimetastatic and immunomodulating effect of water extracts from various mushrooms (2009) J. Acupunct. Meridian Stud, 2 (3), pp. 218-227
• Ma, J., Xue, Y., Liu, W., Yue, C., Bi, F., Xu, J., Zhang, J., Chen, Y., Role of activated rac1/cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer (2013) PLoS One, 8 (6), pp. e66275
• Katz, E., Sims, A.H., Sproul, D., Caldwell, H., Dixon, M.J., Meehan, R.R., Harrison, D.J., Targeting of Rac GTPases blocks the spread of intact human breast cancer (2012) Oncotarget, 3 (6), pp. 608-619
• Jordan, P., Brazåo, R., Boavida, M.G., Gespach, C., Chastre, E., Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors (1999) Oncogene, 18 (48), pp. 6835-6839
• Radisky, D.C., Levy, D.D., Littlepage, L.E., Liu, H., Nelson, C.M., Fata, J.E., Leake, D., Bissell, M.J., Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability (2005) Nature, 436 (7047), pp. 123-127
• Singh, A., Karnoub, A.E., Palmby, T.R., Lengyel, E., Sondek, J., Der, C.J., Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation (2004) Oncogene, 23 (58), pp. 9369-9380
• Herter-Sprie, G.S., Greulich, H., Wong, K.K., Activating mutations in ERBB2 and their impact on diagnostics and treatment (2013) Front. Oncol, 3, p. 86
• Saini, K.S., Loi, S., de Azambuja, E., Metzger-Filho, O., Saini, M.L., Ignatiadis, M., Dancey, J.E., Piccart-Gebhart, M.J., Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer (2013) Cancer Treat. Rev, 39 (8), pp. 935-946
• Jhaveri, K., Modi, S., HSP90 inhibitors for cancer therapy and overcoming drug resistance (2012) Adv. Pharmacol, 65, pp. 471-517
• Aznar, S., Fernández-Valerón, P., Espina, C., Lacal, J.C., Rho GTPases: Potential candidates for anticancer therapy (2004) Cancer Lett, 206 (2), pp. 181-191
• Wang, C.Y., Liu, P.Y., Liao, J.K., Pleiotropic effects of statin therapy: Molecular mechanisms and clinical results (2008) Trends Mol. Med, 14 (1), pp. 37-44
• Tiede, I., Fritz, G., Strand, S., Poppe, D., Dvorsky, R., Strand, D., Lehr, H.A., Neurath, M.F., CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes (2003) J. Clin. Invest, 111 (8), pp. 1133-1145
• Poppe, D., Tiede, I., Fritz, G., Becker, C., Bartsch, B., Wirtz, S., Strand, D., Neurath, M.F., Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac proteins (2006) J. Immunol, 176 (1), pp. 640-651
• Menna, P.L., Parera, R.L., Cardama, G.A., Alonso, D.F., Gomez, D.E., Farina, H.G., Enhanced cytostatic activity of statins in mouse mammary carcinoma cells overexpressing β2-chimaerin (2009) Mol. Med. Report, 2 (1), pp. 97-102
• Gao, Y., Dickerson, J.B., Guo, F., Zheng, J., Zheng, Y., Rational design and characterization of a Rac GTPase-specific small molecule inhibitor (2004) Proc. Natl. Acad. Sci. USA, 101 (20), pp. 7618-7623
• Ferri, N., Corsini, A., Bottino, P., Clerici, F., Contini, A., Virtual screening approach for the identification of new Rac1 inhibitors (2009) J. Med. Chem, 52 (14), pp. 4087-4090
• Hernández, E., De La Mota-Peynado, A., Dharmawardhane, S., Vlaar, C.P., Novel inhibitors of Rac1 in metastatic breast cancer (2010) P R Health Sci. J, 29 (4), pp. 348-356
• Vives, V., Laurin, M., Cres, G., Larrousse, P., Morichaud, Z., Noel, D., Côté, J.F., Blangy, A., The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts (2011) J. Bone Miner. Res, 26 (5), pp. 1099-1110
• Bouquier, N., Vignal, E., Charrasse, S., Weill, M., Schmidt, S., Léonetti, J.P., Blangy, A., Fort, P., A cell active chemical GEF inhibitor selectively targets the Trio/RhoG/Rac1 signaling pathway (2009) Chem. Biol, 16 (6), pp. 657-666
• Blangy, A., Bouquier, N., Gauthier-Rouvière, C., Schmidt, S., Debant, A., Leonetti, J.P., Fort, P., Identification of TRIO-GEFD1 chemical inhibitors using the yeast exchange assay (2006) Biol. Cell, 98 (9), pp. 511-522
• Shutes, A., Onesto, C., Picard, V., Leblond, B., Schweighoffer, F., Der, C.J., Specificity and mechanism of action of EHT 1864, a novel small molecule inhibitor of Rac family small GTPases (2007) J. Biol. Chem, 282 (49), pp. 35666-35678
• Bosco, E.E., Kumar, S., Marchioni, F., Biesiada, J., Kordos, M., Szczur, K., Meller, J., Zheng, Y., Rational design of small molecule inhibitors targeting the Rac GTPase-p67(phox) signaling axis in inflammation (2012) Chem. Biol, 19 (2), pp. 228-242
• Murray, B.W., Guo, C., Piraino, J., Westwick, J.K., Zhang, C., Lamerdin, J., Dagostino, E., Smeal, T., Smallmolecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth (2010) Proc. Natl. Acad. Sci. USA, 107 (20), pp. 9446-9451
• Pearson, H.B., Pouliot, N., Modeling Metastasis In Vivo Metastatic Cancer: Integrated Organ System and Biological Approach, p. 2012. , Rahul Jandial and Kent Hunter, Ed.; Landes Bioscience
• Wertheimer, E., Gutierrez-Uzquiza, A., Rosemblit, C., Lopez-Haber, C., Sosa, M.S., Kazanietz, M.G., Rac signaling in breast cancer: A tale of GEFs and GAPs (2012) Cell Signal, 24 (2), pp. 353-362

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------